Atlas FDA

TANDEM(R)-R CARCINOEMBRYONIC ANTIGEN ASSAY

FDA premarket approval P840019/S005 · decided 1986-11-05

Approval details

PMA number
P840019
Supplement
S005
Supplement type
Normal 180 Day Track
Supplement reason
Other
Trade name
TANDEM(R)-R CARCINOEMBRYONIC ANTIGEN ASSAY
Generic name
SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN
Applicant
Hybritech, Inc.
Date received
1986-09-17
Decision date
1986-11-05
Days to decision
49 days
Decision code
APPR
Product code
DHX
Advisory committee
Immunology
Expedited review
No
Location
San Diego, CA

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TANDEM-MP OSTASE IMMUNOENZYMETRIC ASSAY (K972666)Hybritech, Inc.1997-09-11
TANDEM-R OSTASE IMMUNORADIOMETRIC ASSAY (K961573)Hybritech, Inc.1996-08-19
TANDEM-R OSTASE IMMUNORADIOMETRIC ASSAY (K930810)Hybritech, Inc.1994-01-11
TANDEM-E IGE II CALIBRATION VERIFICATION SET (K922754)Hybritech, Inc.1993-02-17
HYBRITECH STRATUS PAP FLUOROMETRIC ENZYME IMMUNO (K921745)Hybritech, Inc.1992-07-30
TANDEM-E FERRITIN CALIBRATION VERIFICATION CONROL (K921252)Hybritech, Inc.1992-07-17
TANDEM-E HCG CALIBRATION VERIFICATION CONTROL SET (K920556)Hybritech, Inc.1992-07-17
TANDEM ICON QSR CKMB IMMUNOENZYMETRIC ASSAY (K921763)Hybritech, Inc.1992-06-09